VitaNova Life Sciences (VNOV) Cash & Current Investments (2017 - 2026)
VitaNova Life Sciences (VNOV) reported Cash & Current Investments of $1.2 million for Q1 2026, up 188.5% on a YoY basis from $405173.0 in Q1 2025, and down 7.18% quarter-over-quarter from $1.3 million in Q4 2025.
VitaNova Life Sciences (VNOV) Cash & Current Investments (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has reported Cash & Current Investments for 9 years, with the latest figure at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 188.5% year-over-year to $1.2 million; the trailing twelve-month figure through Jan 2026 stood at $1.2 million (up 188.5% YoY), and the FY2025 full-year result was $782810.0, up 32.0% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $1.2 million, down from $1.3 million in the prior quarter.
- The five-year high for Cash & Current Investments was $1.3 million in Q4 2025, with the low at $8728.0 in Q2 2023.
- Historically, Cash & Current Investments has averaged $438297.5 across 5 years, with a median of $222795.0 in 2024.
- Annual changes were most pronounced in 2023 — Cash & Current Investments slumped 70.18% — and 2024, when it soared 7240.02%.
- VitaNova Life Sciences' Cash & Current Investments stood at $36190.0 in 2022, then slumped by 75.88% to $8728.0 in 2023, then soared by 2452.65% to $222795.0 in 2024, then jumped by 465.22% to $1.3 million in 2025, then retreated by 7.18% to $1.2 million in 2026.
- The last three Cash & Current Investments figures came in at $1.2 million (Q1 2026), $1.3 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 176.23 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 3.98 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 2.18 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 3.94 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 138.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 336.88 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 15.00 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 79.14 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 2.16 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1.17 Mn |
| Oct 31, 2025 | 1.26 Mn |
| Jul 31, 2025 | 1.05 Mn |
| Apr 30, 2025 | 782,810.00 |
| Jan 31, 2025 | 405,173.00 |
| Oct 31, 2024 | 222,795.00 |
| Jul 31, 2024 | 141,635.00 |
| Apr 30, 2024 | 593,036.00 |
| Jan 31, 2024 | 808,356.00 |
| Apr 30, 2023 | 8,728.00 |
| Jan 31, 2023 | 11,013.00 |
| Oct 31, 2022 | 36,190.00 |
| Jul 31, 2022 | 29,884.00 |
| Apr 30, 2022 | 23,103.00 |
| Jan 31, 2022 | 36,935.00 |
| Oct 31, 2021 | 31,693.00 |
| Jan 31, 2019 | 50.00 |
| Oct 31, 2018 | 50.00 |
| Jul 31, 2018 | 602.00 |
| Apr 30, 2018 | 4,421.00 |